Cargando…

Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases

AIM: Brain clusterin is known to be associated with the amyloid‐β deposits in Alzheimer's disease (AD). We assessed the distribution of clusterin immunoreactivity in cerebrovascular disorders, particularly focusing on white matter changes in small vessel diseases. METHODS: Post‐mortem brain tis...

Descripción completa

Detalles Bibliográficos
Autores principales: Craggs, Lucinda, Taylor, Julie, Slade, Janet Y., Chen, Aiqing, Hagel, Christian, Kuhlenbaeumer, Gregor, Borjesson‐Hanson, Anne, Viitanen, Matti, Kalimo, Hannu, Deramecourt, Vincent, Oakley, Arthur E., Kalaria, Raj N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949672/
https://www.ncbi.nlm.nih.gov/pubmed/25940137
http://dx.doi.org/10.1111/nan.12248
_version_ 1782443472338288640
author Craggs, Lucinda
Taylor, Julie
Slade, Janet Y.
Chen, Aiqing
Hagel, Christian
Kuhlenbaeumer, Gregor
Borjesson‐Hanson, Anne
Viitanen, Matti
Kalimo, Hannu
Deramecourt, Vincent
Oakley, Arthur E.
Kalaria, Raj N.
author_facet Craggs, Lucinda
Taylor, Julie
Slade, Janet Y.
Chen, Aiqing
Hagel, Christian
Kuhlenbaeumer, Gregor
Borjesson‐Hanson, Anne
Viitanen, Matti
Kalimo, Hannu
Deramecourt, Vincent
Oakley, Arthur E.
Kalaria, Raj N.
author_sort Craggs, Lucinda
collection PubMed
description AIM: Brain clusterin is known to be associated with the amyloid‐β deposits in Alzheimer's disease (AD). We assessed the distribution of clusterin immunoreactivity in cerebrovascular disorders, particularly focusing on white matter changes in small vessel diseases. METHODS: Post‐mortem brain tissues from the frontal or temporal lobes of a total of 70 subjects with various disorders including cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), cerebral amyloid angiopathy (CAA) and AD were examined using immunohistochemistry and immunofluorescence. We further used immunogold electron microscopy to study clusterin immunoreactivity in extracellular deposits in CADASIL. RESULTS: Immunostaining with clusterin antibodies revealed strong localization in arterioles and capillaries, besides cortical neurones. We found that clusterin immunostaining was significantly increased in the frontal white matter of CADASIL and pontine autosomal dominant microangiopathy and leukoencephalopathy subjects. In addition, clusterin immunostaining correlated with white matter pathology severity scores. Immunostaining in axons ranged from fine punctate deposits in single axons to larger confluent areas with numerous swollen axon bulbs, similar to that observed with known axon damage markers such as non‐phosphorylated neurofilament H and the amyloid precursor protein. Immunofluorescence and immunogold electron microscopy experiments showed that whereas clusterin immunoreactivity was closely associated with vascular amyloid‐β in CAA, it was lacking within the granular osmiophilic material immunolabelled by NOTCH3 extracelluar domain aggregates found in CADASIL. CONCLUSIONS: Our results suggest a wider role for clusterin associated with white matter damage in addition to its ability to chaperone proteins for clearance via the perivascular drainage pathways in several disease states.
format Online
Article
Text
id pubmed-4949672
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49496722016-07-28 Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases Craggs, Lucinda Taylor, Julie Slade, Janet Y. Chen, Aiqing Hagel, Christian Kuhlenbaeumer, Gregor Borjesson‐Hanson, Anne Viitanen, Matti Kalimo, Hannu Deramecourt, Vincent Oakley, Arthur E. Kalaria, Raj N. Neuropathol Appl Neurobiol Original Articles AIM: Brain clusterin is known to be associated with the amyloid‐β deposits in Alzheimer's disease (AD). We assessed the distribution of clusterin immunoreactivity in cerebrovascular disorders, particularly focusing on white matter changes in small vessel diseases. METHODS: Post‐mortem brain tissues from the frontal or temporal lobes of a total of 70 subjects with various disorders including cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), cerebral amyloid angiopathy (CAA) and AD were examined using immunohistochemistry and immunofluorescence. We further used immunogold electron microscopy to study clusterin immunoreactivity in extracellular deposits in CADASIL. RESULTS: Immunostaining with clusterin antibodies revealed strong localization in arterioles and capillaries, besides cortical neurones. We found that clusterin immunostaining was significantly increased in the frontal white matter of CADASIL and pontine autosomal dominant microangiopathy and leukoencephalopathy subjects. In addition, clusterin immunostaining correlated with white matter pathology severity scores. Immunostaining in axons ranged from fine punctate deposits in single axons to larger confluent areas with numerous swollen axon bulbs, similar to that observed with known axon damage markers such as non‐phosphorylated neurofilament H and the amyloid precursor protein. Immunofluorescence and immunogold electron microscopy experiments showed that whereas clusterin immunoreactivity was closely associated with vascular amyloid‐β in CAA, it was lacking within the granular osmiophilic material immunolabelled by NOTCH3 extracelluar domain aggregates found in CADASIL. CONCLUSIONS: Our results suggest a wider role for clusterin associated with white matter damage in addition to its ability to chaperone proteins for clearance via the perivascular drainage pathways in several disease states. John Wiley and Sons Inc. 2015-06-17 2016-02 /pmc/articles/PMC4949672/ /pubmed/25940137 http://dx.doi.org/10.1111/nan.12248 Text en © 2015 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd on behalf of British Neuropathological Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Craggs, Lucinda
Taylor, Julie
Slade, Janet Y.
Chen, Aiqing
Hagel, Christian
Kuhlenbaeumer, Gregor
Borjesson‐Hanson, Anne
Viitanen, Matti
Kalimo, Hannu
Deramecourt, Vincent
Oakley, Arthur E.
Kalaria, Raj N.
Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases
title Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases
title_full Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases
title_fullStr Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases
title_full_unstemmed Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases
title_short Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases
title_sort clusterin/apolipoprotein j immunoreactivity is associated with white matter damage in cerebral small vessel diseases
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949672/
https://www.ncbi.nlm.nih.gov/pubmed/25940137
http://dx.doi.org/10.1111/nan.12248
work_keys_str_mv AT craggslucinda clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases
AT taylorjulie clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases
AT sladejanety clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases
AT chenaiqing clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases
AT hagelchristian clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases
AT kuhlenbaeumergregor clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases
AT borjessonhansonanne clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases
AT viitanenmatti clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases
AT kalimohannu clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases
AT deramecourtvincent clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases
AT oakleyarthure clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases
AT kalariarajn clusterinapolipoproteinjimmunoreactivityisassociatedwithwhitematterdamageincerebralsmallvesseldiseases